Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system

P. Maresova, L. Rezny, P. Bauer, M. Valko, K. Kuca

. 2024 ; 24 (1) : 1293. [pub] 20240513

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013948

Grantová podpora
ERDF No. CZ.02.1.01/0.0/0.0/18_069/0010054-IT4Neuro(degeneration) Ministry of Education Youth and Sports
Excellence 2022 UHK FIM

BACKGROUND: New effective treatments for dementia are lacking, and early prevention focusing on risk factors of dementia is important. Non-pharmacological intervention therapies aimed at these factors may provide a valuable tool for reducing the incidence of dementia. This study focused on the development of a mathematical model to predict the number of individuals with neurodegenerative diseases, specifically Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis. Scenarios for non-pharmacological intervention therapies based on risk factor reduction were also assessed. The estimated total costs and potential cost savings from societal were included. METHODS: Based on demographic and financial data from the EU, a mathematical model was developed to predict the prevalence and resulting care costs of neurodegenerative diseases in the population. Each disease (Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis) used parameters that included prevalence, incidence, and death risk ratio, and the simulation is related to the age of the cohort and the disease stage. RESULTS: A replicable simulation for predicting the prevalence and resulting cost of care for neurodegenerative diseases in the population exhibited an increase in treatment costs from 267 billion EUR in 2021 to 528 billion EUR by 2050 in the EU alone. Scenarios related to the reduction of the prevalence of dementia by up to 20% per decade led to total discounted treatment cost savings of up to 558 billion EUR. CONCLUSION: The model indicates the magnitude of the financial burden placed on EU healthcare systems due to the growth in the population prevalence of neurodegenerative diseases in the coming decades. Lifestyle interventions based on reducing the most common risk factors could serve as a prevention strategy to reduce the incidence of dementia with substantial cost-savings potential. These findings could support the implementation of public health approaches throughout life to ultimately prevent premature mortality and promote a healthier and more active lifestyle in older individuals.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013948
003      
CZ-PrNML
005      
20240905133919.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12889-024-18773-7 $2 doi
035    __
$a (PubMed)38741111
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Maresova, Petra $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic
245    10
$a Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system / $c P. Maresova, L. Rezny, P. Bauer, M. Valko, K. Kuca
520    9_
$a BACKGROUND: New effective treatments for dementia are lacking, and early prevention focusing on risk factors of dementia is important. Non-pharmacological intervention therapies aimed at these factors may provide a valuable tool for reducing the incidence of dementia. This study focused on the development of a mathematical model to predict the number of individuals with neurodegenerative diseases, specifically Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis. Scenarios for non-pharmacological intervention therapies based on risk factor reduction were also assessed. The estimated total costs and potential cost savings from societal were included. METHODS: Based on demographic and financial data from the EU, a mathematical model was developed to predict the prevalence and resulting care costs of neurodegenerative diseases in the population. Each disease (Alzheimer's disease, Parkinson's disease, vascular dementia, and amyotrophic lateral sclerosis) used parameters that included prevalence, incidence, and death risk ratio, and the simulation is related to the age of the cohort and the disease stage. RESULTS: A replicable simulation for predicting the prevalence and resulting cost of care for neurodegenerative diseases in the population exhibited an increase in treatment costs from 267 billion EUR in 2021 to 528 billion EUR by 2050 in the EU alone. Scenarios related to the reduction of the prevalence of dementia by up to 20% per decade led to total discounted treatment cost savings of up to 558 billion EUR. CONCLUSION: The model indicates the magnitude of the financial burden placed on EU healthcare systems due to the growth in the population prevalence of neurodegenerative diseases in the coming decades. Lifestyle interventions based on reducing the most common risk factors could serve as a prevention strategy to reduce the incidence of dementia with substantial cost-savings potential. These findings could support the implementation of public health approaches throughout life to ultimately prevent premature mortality and promote a healthier and more active lifestyle in older individuals.
650    _2
$a lidé $7 D006801
650    12
$a demence $x ekonomika $x epidemiologie $x prevence a kontrola $7 D003704
650    _2
$a rizikové faktory $7 D012307
650    _2
$a úspory nákladů $7 D017046
650    _2
$a senioři $7 D000368
650    _2
$a náklady na zdravotní péči $x statistika a číselné údaje $7 D017048
650    _2
$a teoretické modely $7 D008962
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a prevalence $7 D015995
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a lidé středního věku $7 D008875
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rezny, Lukas $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic
700    1_
$a Bauer, Petr $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic
700    1_
$a Valko, Marian $u Slovak University of Technology, Bratislava, 81237, Slovakia
700    1_
$a Kuca, Kamil $u Faculty of Informatics and Management, University of Hradec Kralove, Rokitanského 62, Hradec Kralove, 50003, Czech Republic. kamil.kuca@uhk.cz $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, 50005, Czech Republic. kamil.kuca@uhk.cz $u Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, 18071, Spain. kamil.kuca@uhk.cz
773    0_
$w MED00008205 $t BMC public health $x 1471-2458 $g Roč. 24, č. 1 (2024), s. 1293
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38741111 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133913 $b ABA008
999    __
$a ok $b bmc $g 2143637 $s 1225814
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 1 $d 1293 $e 20240513 $i 1471-2458 $m BMC public health $n BMC Public Health $x MED00008205
GRA    __
$a ERDF No. CZ.02.1.01/0.0/0.0/18_069/0010054-IT4Neuro(degeneration) $p Ministry of Education Youth and Sports
GRA    __
$a Excellence 2022 $p UHK FIM
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...